State-Backed Commercialization: Projecting the Long-Term Market Forecast for CAR T-Cell Therapy Penetration in China's Healthcare System
  The China CAR T Cell Therapy Market stands as a global powerhouse of innovation and commercial velocity, distinguished by its aggressive pace of clinical development and substantial government backing. China has rapidly evolved from a follower to a frontrunner in cell and gene therapies, primarily due to a confluence of factors: a large, treatment-naive patient population with a high...
0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior